Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflammation and cancer: advances and new agents.
Crusz SM, Balkwill FR. Crusz SM, et al. Nat Rev Clin Oncol. 2015 Oct;12(10):584-96. doi: 10.1038/nrclinonc.2015.105. Epub 2015 Jun 30. Nat Rev Clin Oncol. 2015. PMID: 26122183 Review.
Sequencing systemic therapies in advanced RCC: is there a best strategy?
Powles T, Crusz SM. Powles T, et al. Among authors: crusz sm. Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e172. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714492 Free article. Review.
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma.
Crusz SM, Tang YZ, Sarker SJ, Prevoo W, Kiyani I, Beltran L, Peters J, Sahdev A, Bex A, Powles T, Gerlinger M. Crusz SM, et al. BMC Med. 2016 Nov 14;14(1):185. doi: 10.1186/s12916-016-0729-9. BMC Med. 2016. PMID: 27842541 Free PMC article.
Targeted therapies in gynaecological cancers.
Crusz SM, Miller RE. Crusz SM, et al. Histopathology. 2020 Jan;76(1):157-170. doi: 10.1111/his.14009. Histopathology. 2020. PMID: 31846530 Review.
Caring for our cancer patients in the wake of COVID-19.
El-Shakankery KH, Kefas J, Crusz SM. El-Shakankery KH, et al. Among authors: crusz sm. Br J Cancer. 2020 Jul;123(1):3-4. doi: 10.1038/s41416-020-0843-5. Epub 2020 Apr 17. Br J Cancer. 2020. PMID: 32303717 Free PMC article.
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.
Neuzillet C, Casadei Gardini A, Brieau B, Vivaldi C, Smolenschi C, Brandi G, Tougeron D, Filippi R, Vienot A, Silvestris N, Pointet AL, Lonardi S, Rousseau B, Scartozzi M, Dahan L, Aprile G, Boussaha T, Malka D, Crusz SM, Le Sourd S, Meurisse A, Lièvre A, Vernerey D; AGEO (Association des Gastro-Entérologues Oncologues); GICO (Italian Group of Cholangiocarcinoma) Investigators; Gustave Roussy Institute Cohort; Barts Cancer Institute Cohort. Neuzillet C, et al. Among authors: crusz sm. Eur J Cancer. 2019 Apr;111:94-106. doi: 10.1016/j.ejca.2019.01.019. Epub 2019 Mar 1. Eur J Cancer. 2019. PMID: 30826661 Free article. Clinical Trial.
Rituximab in the treatment of pembrolizumab-induced myasthenia gravis.
Crusz SM, Radunovic A, Shepherd S, Shah S, Newey V, Phillips M, Lim L, Powles T, Szlosarek PW, Shamash J, Rashid S. Crusz SM, et al. Eur J Cancer. 2018 Oct;102:49-51. doi: 10.1016/j.ejca.2018.07.125. Epub 2018 Aug 20. Eur J Cancer. 2018. PMID: 30138772 No abstract available.
Feedback